As the MACs began to discuss Cures Act adjustment activity, Andrea Stark fiercely advocated for a unique remark code on EOBs to identify these adjustments. Despite compelling arguments, the CGS Summary Article on May 9 indicated Cures adjustments would not have a unique identifier.
However, MiraVista recently learned that the DME MACs continued to work behind the scenes with CMS to accommodate the request and decided to use existing remark code N689: "This reversal is due to a retroactive rate change." Suppliers can expect to see this remark code with Cures adjustments beginning in early July.
However, MiraVista recently learned that the DME MACs continued to work behind the scenes with CMS to accommodate the request and decided to use existing remark code N689: "This reversal is due to a retroactive rate change." Suppliers can expect to see this remark code with Cures adjustments beginning in early July.
RSS Feed